Dr. Seddon R. Savage

• 
  www.ETHICSCOMMITTEE.COM/media/speaker_bio.php?speaker_i - [Cached Version]
  Last Visited: 7/14/2009  

  Seddon Savage, M.D. Pain Consultant American Society of Addiction Medicine
  ...
  She is certified in pain medicine by the American Board of Anesthesiology and the American Board of Pain Medicine and in addiction medicine by the American Society of Addiction Medicine (ASAM). She is a fellow of ASAM. Dr. Savage is an associate professor of anesthesiology on the adjunct faculty of Dartmouth Medical School and serves as a pain consultant at the U.S. Veteran's Administration Medical Center Manchester. She chairs the ASAM Pain Committee and the Liaison Committee on Pain and Addiction, a joint committee of ASAM, the American Pain Society and the American Academy of Pain Medicine. The Committee addresses interfacing areas in pain medicine and addiction medicine. Additionally, she serves on the Executive Committee and Physician Health Committee of the New Hampshire Medical Society and chairs the Medical Society Task Force on Pain and the Task Force on End of Life Care. She is a frequent lecturer on topics related to pain and addiction and has published a number of articles on these issues.

• 
  www.news-register.net/page/content.detail/id/509372.htm - [Cached Version]
  Published on: 5/11/2008    Last Visited: 5/11/2008  

  More from Dr. Savage:
  ...
  More from Dr. Savage:
  ...
  From Seddon Savage, a physician, the director of the Dartmouth Center on Addiction Recovery and Education and the mother of three children, ages 15, 18 and 20:

• 
  www.ampainsoc.org/whoswho/board.htm - [Cached Version]
  Published on: 1/1/2006    Last Visited: 3/5/2007  

  Seddon R. Savage, MD (07)
  
  Director, Dartmouth Center on Addiction Recovery and Education40 North College StreetHanover, NH 03755 603/646-9215Fax: 603/646-9151

• 
  www.cannabisnews.com/news/thread24474.shtml - [Cached Version]
  Published on: 2/10/2009    Last Visited: 2/11/2009  

  Marijuana's active components, cannabinoids, "do have medical benefits," said Seddon Savage, a doctor who specializes in addiction medicine and pain medication and who sits on the board of the New Hampshire Medical Society. Cannabinoids have been studied for use as treatments for pain, nausea and lack of appetite, she said. While drug companies have tried to incorporate synthetic cannabinoids into medicines, so far the drugs available in the United States have not been as "bioavailable," and therefore as effective, as smoked marijuana has, Savage said. "One of the problems with the currently available cannabinoids is . . . they don't have all the constituents that smoked marijuana has," Savage said. But Savage has her eye on a new cannabinoid drug, Sativex, an oral spray recently approved in Canada that is in the trial phase with the FDA, and which she said has proven to be an "excellent pain drug." Savage, who is not taking a position on medical marijuana, notes that the act of smoking comes with harmful side effects. And she adds that the lack of a regularized form of marijuana makes it hard for physicians to prescribe. "In general, in medicine, we like to have some level of certainty about what it is we're actually providing patients," she said. To Rep.

• 
  www.pcssbuprenorphine.org/pcss/about_experts.php - [Cached Version]
  Last Visited: 6/29/2009  

  Seddon Savage American Pain Society

• 
  www.morelaw.com/verdicts/case.asp?n=07-1945&s=NH&d=3811 - [Cached Version]
  Published on: 11/28/2008    Last Visited: 12/12/2008  

  Also testifying in favor of the legislation was the president-elect of the New Hampshire Medical Society, Dr. Seddon Savage, who said the law "will deter marketing intended to manipulate the practice of individual physicians that is intended to increase market share for the individual companies, possibly at the expense of appropriate decision making for the patients." He further stated that "[n]umerous studies have shown that . . . [doctors'] decision making can be and sometimes is shaped by marketing efforts."
  ...
  Savage, president-elect of the New Hampshire Medical Society, testified at the Senate committee hearing that "[n]umerous studies" have shown that doctors' prescribing decisions "can be and sometimes [are] shaped by marketing efforts."

• 
  www.cascadehealth.org/articles/Do_Pain_Meds_Lead_to_Dru - [Cached Version]
  Published on: 2/14/2008    Last Visited: 2/14/2008  

  "It's a common concern for both patients and health providers," says Seddon Savage, M.D., a pain specialist at Dartmouth Medical School, who specializes in addiction."Most forms of chronic pain respond to non-opioid drug treatments," she says.
  
  Examples of non-opioid pain relievers, which don't have addiction potential, include aspirin, acetaminophen, ibuprofen, naproxen, and other non-steroidal anti-inflammatory drugs.A combination of different types of analgesic medications at lower doses is often more effective than a single high-dose medication.
  
  "But if opioids are prescribed for your pain, you are not abusing drugs if you are taking the medication as prescribed," Savage says.
  ...
  Savage says that in prescribing potentially addictive medications, doctors should consider patients' personal and family histories of addiction, as well as psychological and social stressors that may affect medication use.

• 
  www.cannabisnews.com/news/thread24474.shtml - [Cached Version]
  Published on: 6/29/2009    Last Visited: 6/29/2009  

  Marijuana's active components, cannabinoids, "do have medical benefits," said Seddon Savage, a doctor who specializes in addiction medicine and pain medication and who sits on the board of the New Hampshire Medical Society. Cannabinoids have been studied for use as treatments for pain, nausea and lack of appetite, she said. While drug companies have tried to incorporate synthetic cannabinoids into medicines, so far the drugs available in the United States have not been as "bioavailable," and therefore as effective, as smoked marijuana has, Savage said. "One of the problems with the currently available cannabinoids is . . . they don't have all the constituents that smoked marijuana has," Savage said. But Savage has her eye on a new cannabinoid drug, Sativex, an oral spray recently approved in Canada that is in the trial phase with the FDA, and which she said has proven to be an "excellent pain drug. Savage, who is not taking a position on medical marijuana, notes that the act of smoking comes with harmful side effects. And she adds that the lack of a regularized form of marijuana makes it hard for physicians to prescribe. "In general, in medicine, we like to have some level of certainty about what it is we're actually providing patients," she said. To Rep.

• 
  www.iapcd.com/at-a-glance.php - [Cached Version]
  Published on: 3/24/2007    Last Visited: 3/24/2007  

  Seddon R. Savage, MDDirector, Dartmouth Center on Addiction Recovery and EducationDartmouth Medical School
  ...
  Moderator: Seddon R. Savage, MD
  ...
  Seddon R. Savage, MD

• 
  www.fmaware.org/fmOnlineNewsletter/2004/vol4_no5/articl - [Cached Version]
  Published on: 1/1/2004    Last Visited: 3/20/2007  

  Seddon R. Savage, MD, Dartmouth Medical Center

Page:  1 2 3 4 5